Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Quattro74on Aug 19, 2020 3:28pm
140 Views
Post# 31430232

RE:RE:RE:RE:RE:RE:RE:RE:Wow

RE:RE:RE:RE:RE:RE:RE:RE:WowThanks Doc,

I hope they don't fumble on this UM study, showcase their Vaccine tech. get high % efficacy in chimps or whomever. Keeping fingers crossed on this one...

Hempdoc wrote:
Quattro74 wrote:
Hempdoc wrote:
menoalittle wrote: yeah, very interesting developments today for sure...

lots of newbies buy TLT looking for some hot trading action related to COVID-19...
professional shorting wolf packs see it as hype and short the chit out it...
volume and % gain in stock draws national news and interest to TLT the next day or two...
newbies hear and read more... suddenly realize TLT has probable cure for cancer...
newbies, realizing they've accidentally stumbled into something great, rush to buy up more TLT...
began telling friends & family... who also rush in to buy more...
old time TLT stock holders (who know what they have) refuse to sell any...
continued rise in price and volume draws more national news coverage...
pro short wolf packs chit their drawers, began to panic buy attempting to cover big losses...

oh my... starts a vicious upward spiral...
(to the moon, Alice... to the moon.)


 


Well said...poor chaps had no idea what was coming.  It was only a matter of time....as I emphasized to Goldy in my last post ; )  Important point:  When a compound like this starts getting independently verified by multiple independent sources across multiple indications, you're getting very close to raising the checkered flag.  This is a "major" milestone & the de risk has been elevated to a new level.  Shorters beware...

Dr. Coombs was able to prove high efficacy amongst "more than one" & "unrelated" enveloped viruses (a flu strain & Zika).  The clinical significance of this discovery & TLD1433's potential use as a "general antiviral" is enormous.   Think of the "numerous" other enveloped viruses that cause significant human disease, many of which have devastating human/economic impacts despite available therapies (coronavirus, paramyxovirus, herpes virus, hepatitis virus, dengue/flavivirus & HIV to name a few).   RPCCC, UM & many more to come Goldy ; ).  Very exciting...good luck all.
 



I wonder when they started this process Doc? Did it take this long to get a credible research Doctor to look into this officially? Anyway, I'm very happy that they will begin to get some recognition. I'm amazed it is taking Covid to highlight their tech regarding Virus/Bacteria. This could/should get them their next round of financing, maybe from a Govt. grant? Maybe from the US Govt.?

I'm guessing this all works via Warburg effect, ie Oxygen. So this is a nanotech solution, perhaps the first, to be used to attack Covid 19. If it works in animals it will work in Humans. 100%
 


 

 

Like cancer, viruses objective is to hyjack our cellular machinery in order to survive & proliferate.  The beauty of the TLD 1433 lies in its mechanism of action.  It doesn't seem to care if you are a cancer or a virus.  Certain heavy metals (like Ruthenium, Copper) act like molecular grenades against "any" pathogenic source due to its unique atomic structure & their ability to take part in free-radical generating reactions (the grenades).  Copper's disinfectant properties have been well-known for millennia & I believe Ruthenium will be the ion of choice for so many applications.  Would be interesting to test the disinfecting capabilities of Ruthenium-infused medical materials (hospital beds, sheets, handrails & other surfaces).  Ru may just be the new gold, but I'll be happy with silver : )



<< Previous
Bullboard Posts
Next >>